vs
INVESTORS TITLE CO（ITIC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是INVESTORS TITLE CO的1.1倍（$75.5M vs $69.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -1.6%），INVESTORS TITLE CO自由现金流更多（$25.4M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 14.0%）
该公司是全球首家产权保险公司，前身为费城房地产产权保险公司，目前专注于为房地产交易提供产权保险相关服务，保障房地产交易中产权方的合法权益，在产权保险领域拥有悠久的发展历史与行业积累。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ITIC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$69.5M
营收增速更快
PBYI
高出29.3%
-1.6%
自由现金流更多
ITIC
多$11.0M
$14.4M
两年增速更快
PBYI
近两年复合增速
14.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.5M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 13.8% | 22.7% |
| 净利率 | — | — |
| 营收同比 | -1.6% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $3.97 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ITICPBYI
| Q4 25 | $69.5M | $75.5M | ||
| Q3 25 | $73.0M | $54.5M | ||
| Q2 25 | $73.6M | $52.4M | ||
| Q1 25 | $56.6M | $46.0M | ||
| Q4 24 | $70.6M | $59.1M | ||
| Q3 24 | $68.8M | $80.5M | ||
| Q2 24 | $65.4M | $47.1M | ||
| Q1 24 | $53.5M | $43.8M |
净利润ITICPBYI
| Q4 25 | — | — | ||
| Q3 25 | $12.2M | $8.8M | ||
| Q2 25 | $12.3M | $5.9M | ||
| Q1 25 | $3.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.3M | $20.3M | ||
| Q2 24 | $8.9M | $-4.5M | ||
| Q1 24 | $4.5M | $-4.8M |
毛利率ITICPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ITICPBYI
| Q4 25 | 13.8% | 22.7% | ||
| Q3 25 | 20.7% | 17.6% | ||
| Q2 25 | 21.5% | 12.7% | ||
| Q1 25 | 7.2% | 8.7% | ||
| Q4 24 | 15.3% | 22.6% | ||
| Q3 24 | 16.8% | 27.4% | ||
| Q2 24 | 17.2% | -4.6% | ||
| Q1 24 | 10.8% | -5.3% |
净利率ITICPBYI
| Q4 25 | — | — | ||
| Q3 25 | 16.7% | 16.2% | ||
| Q2 25 | 16.7% | 11.2% | ||
| Q1 25 | 5.6% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 13.5% | 25.2% | ||
| Q2 24 | 13.6% | -9.6% | ||
| Q1 24 | 8.5% | -11.0% |
每股收益（稀释后）ITICPBYI
| Q4 25 | $3.97 | $0.26 | ||
| Q3 25 | $6.45 | $0.17 | ||
| Q2 25 | $6.48 | $0.12 | ||
| Q1 25 | $1.67 | $0.06 | ||
| Q4 24 | $4.41 | $0.40 | ||
| Q3 24 | $4.92 | $0.41 | ||
| Q2 24 | $4.70 | $-0.09 | ||
| Q1 24 | $2.40 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $268.3M | $130.3M |
| 总资产 | $363.1M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ITICPBYI
| Q4 25 | $89.6M | $97.5M | ||
| Q3 25 | $110.8M | $94.4M | ||
| Q2 25 | $90.1M | $96.0M | ||
| Q1 25 | $81.7M | $93.2M | ||
| Q4 24 | $83.8M | $101.0M | ||
| Q3 24 | $112.9M | $96.7M | ||
| Q2 24 | $111.2M | $96.8M | ||
| Q1 24 | $135.0M | $107.2M |
总债务ITICPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ITICPBYI
| Q4 25 | $268.3M | $130.3M | ||
| Q3 25 | $278.0M | $115.3M | ||
| Q2 25 | $266.2M | $104.7M | ||
| Q1 25 | $254.4M | $97.1M | ||
| Q4 24 | $251.8M | $92.1M | ||
| Q3 24 | $271.3M | $71.1M | ||
| Q2 24 | $261.8M | $48.5M | ||
| Q1 24 | $254.0M | $51.0M |
总资产ITICPBYI
| Q4 25 | $363.1M | $216.3M | ||
| Q3 25 | $363.3M | $202.9M | ||
| Q2 25 | $345.8M | $194.9M | ||
| Q1 25 | $333.8M | $196.2M | ||
| Q4 24 | $333.6M | $213.3M | ||
| Q3 24 | $352.0M | $220.7M | ||
| Q2 24 | $340.3M | $205.0M | ||
| Q1 24 | $329.5M | $214.1M |
负债/权益比ITICPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $30.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $25.4M | $14.4M |
| 自由现金流率自由现金流/营收 | 36.5% | 19.1% |
| 资本支出强度资本支出/营收 | 8.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $47.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ITICPBYI
| Q4 25 | $30.9M | $14.4M | ||
| Q3 25 | $17.2M | $9.7M | ||
| Q2 25 | $8.9M | $14.1M | ||
| Q1 25 | $-75.0K | $3.6M | ||
| Q4 24 | $29.8M | $15.6M | ||
| Q3 24 | $7.8M | $11.0M | ||
| Q2 24 | $8.4M | $1.0M | ||
| Q1 24 | $1.4M | $11.2M |
自由现金流ITICPBYI
| Q4 25 | $25.4M | $14.4M | ||
| Q3 25 | $15.8M | $9.7M | ||
| Q2 25 | $7.3M | $14.1M | ||
| Q1 25 | $-1.4M | $3.6M | ||
| Q4 24 | $22.4M | $15.6M | ||
| Q3 24 | $6.1M | $11.0M | ||
| Q2 24 | $6.3M | $1.0M | ||
| Q1 24 | $-793.0K | — |
自由现金流率ITICPBYI
| Q4 25 | 36.5% | 19.1% | ||
| Q3 25 | 21.7% | 17.7% | ||
| Q2 25 | 9.9% | 26.8% | ||
| Q1 25 | -2.5% | 7.7% | ||
| Q4 24 | 31.7% | 26.4% | ||
| Q3 24 | 8.8% | 13.7% | ||
| Q2 24 | 9.7% | 2.1% | ||
| Q1 24 | -1.5% | — |
资本支出强度ITICPBYI
| Q4 25 | 8.0% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 2.1% | 0.0% | ||
| Q1 25 | 2.4% | 0.1% | ||
| Q4 24 | 10.5% | 0.0% | ||
| Q3 24 | 2.5% | 0.0% | ||
| Q2 24 | 3.2% | 0.0% | ||
| Q1 24 | 4.2% | 0.0% |
现金转化率ITICPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.40× | 1.10× | ||
| Q2 25 | 0.72× | 2.41× | ||
| Q1 25 | -0.02× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.84× | 0.54× | ||
| Q2 24 | 0.95× | — | ||
| Q1 24 | 0.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
